Education
About Us
Working with TipRanks
Follow Us
Neil William Aubuchon Insider Profile
4 Followers
Neil William Aubuchon, CCO at Viking Therapeutics, holds 4.47K shares in Viking Therapeutics (Ticker: VKTX). Most recently, Neil William Aubuchon Bought 4,475 shares of Viking Therapeutics on Mar 10, 2026 for an estimated value of $149.91K.
Neil William Aubuchon has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Neil William Aubuchon's holdings
Insider Roles
CCO
Roles that Neil William Aubuchon holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Neil William Aubuchon
Neil William Aubuchon's Trading History
List of latest transactions for each holding click on a transaction to see Neil William Aubuchon's performance on stock
You May Also Like
Neil William Aubuchon insider profile FAQ
What is the percentage of profitable transactions made by Neil William Aubuchon?
The percentage of profitable transactions made by Neil William Aubuchon is ―.
What is the average return per transaction made by Neil William Aubuchon?
The average return per transaction made by Neil William Aubuchon is ―.
What stocks does Neil William Aubuchon hold?
Neil William Aubuchon holds: VKTX stocks.
What was Neil William Aubuchon’s latest transaction?
Neil William Aubuchon latest transaction was an Informative Buy of $149.91K.
What was Neil William Aubuchon's most profitable transaction?
Neil William Aubuchon’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Neil William Aubuchon's role in Viking Therapeutics?
Neil William Aubuchon's role in Viking Therapeutics is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.